Open Access 01-12-2012 | Commentary
Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
Published in: Journal of Translational Medicine | Issue 1/2012
Login to get access